These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10780456)

  • 1. Specific RNA protease inhibitors from in vitro selection.
    Yamamoto S; Saito S; Tanaka T; Kikuchi Y
    Nucleic Acids Symp Ser; 1999; (42):215-6. PubMed ID: 10780456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of an RNA molecule that specifically inhibits the protease activity of subtilisin.
    Takeno H; Yamamoto S; Tanaka T; Sakano Y; Kikuchi Y
    J Biochem; 1999 Jun; 125(6):1115-9. PubMed ID: 10348914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA aptamers to a protease, subtilisin.
    Takeno H; Tanaka T; Kikuchi Y
    Nucleic Acids Symp Ser; 1997; (37):249-50. PubMed ID: 9586093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tertiary structure formation in the propeptide of subtilisin BPN' by successive amino acid replacements and its close relation to function.
    Kojima S; Minagawa T; Miura K
    J Mol Biol; 1998 Apr; 277(5):1007-13. PubMed ID: 9571018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protease inhibitor produced by Streptomyces lividans 66 exhibits inhibitory activities toward both subtilisin BPN' and trypsin.
    Ueda Y; Kojima S; Tsumoto K; Takeda S; Miura K; Kumagai I
    J Biochem; 1992 Aug; 112(2):204-11. PubMed ID: 1356971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of inhibitory properties of Pleurotus ostreatus proteinase A inhibitor 1 by mutation of its C-terminal region.
    Kojima S; Hisano Y; Miura K
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1271-6. PubMed ID: 11243873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of subtilisin BPN' and recombinant fungal protease inhibitor F from silkworm with substituted P1 site residues.
    Taniguchi M; Atiwetin P; Hirai T; Itoh M; Harada S; Hara S; Kamei K
    Biosci Biotechnol Biochem; 2006 May; 70(5):1262-4. PubMed ID: 16717433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific RNA aptamers to NS3 protease domain of hepatitis C virus.
    Fukuda K; Vishinuvardhan D; Sekiya S; Kakiuchi N; Shimotohno K; Kumar PK; Nishikawa S
    Nucleic Acids Symp Ser; 1997; (37):237-8. PubMed ID: 9586087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic studies of the inhibitory effects of propeptides subtilisin BPN' and Carlsberg to bacterial serine proteases.
    Huang HW; Chen WC; Wu CY; Yu HC; Lin WY; Chen ST; Wang KT
    Protein Eng; 1997 Oct; 10(10):1227-33. PubMed ID: 9488148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structures of Streptomyces subtilisin inhibitor and its complex with subtilisin BPN'.
    Mitsui Y; Satow Y; Watanabe Y; Hirono S; Iitaka Y
    Nature; 1979 Feb; 277(5696):447-52. PubMed ID: 763329
    [No Abstract]   [Full Text] [Related]  

  • 11. The propeptide of subtilisin BPN' as a temporary inhibitor and effect of an amino acid replacement on its inhibitory activity.
    Kojima S; Minagawa T; Miura K
    FEBS Lett; 1997 Jul; 411(1):128-32. PubMed ID: 9247157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing subtilisin BPN' to cleave substrates containing dibasic residues.
    Ballinger MD; Tom J; Wells JA
    Biochemistry; 1995 Oct; 34(41):13312-9. PubMed ID: 7577915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel protease inhibitors via computational redesign of subtilisin BPN' propeptide.
    Daugherty AB; Muthu P; Lutz S
    Biochemistry; 2012 Oct; 51(41):8247-55. PubMed ID: 23009354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of subtilisin BPN' by reaction site P1 mutants of Streptomyces subtilisin inhibitor.
    Kojima S; Nishiyama Y; Kumagai I; Miura K
    J Biochem; 1991 Mar; 109(3):377-82. PubMed ID: 1908859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the C-terminal region of yeast proteinase B inhibitor 2 in its inhibitory action.
    Kojima S; Deguchi M; Miura K
    J Mol Biol; 1999 Feb; 286(3):775-85. PubMed ID: 10024450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular recognition at the active site of subtilisin BPN': crystallographic studies using genetically engineered proteinaceous inhibitor SSI (Streptomyces subtilisin inhibitor).
    Takeuchi Y; Noguchi S; Satow Y; Kojima S; Kumagai I; Miura K; Nakamura KT; Mitsui Y
    Protein Eng; 1991 Jun; 4(5):501-8. PubMed ID: 1891457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further studies on the interaction between a protein proteinase inhibitor, Streptomyces subtilisin inhibitor, and thiolsubtilisin BPN'.
    Inouye K; Tonomura B; Hiromi K; Fujiwara K; Tsuru D
    J Biochem; 1979 May; 85(5):1127-34. PubMed ID: 36373
    [No Abstract]   [Full Text] [Related]  

  • 18. A new substrate and two inhibitors applicable for thermitase, subtilisin BPN' and alpha-chymotrypsin. Comparison of kinetic parameters with customary substrates and inhibitors.
    Brömme D; Fittkau S
    Biomed Biochim Acta; 1985; 44(7-8):1089-94. PubMed ID: 3910035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The determination of molecular weights of Streptomyces subtilisin inhibitor and the complex of Streptomyces subtilisin inhibitor and subtilisin BPN' by sedimentation equilibrium.
    Inouye K; Tonomura B; Hiromi K; Kotaka T; Inagaki H; Sato S; Murao S
    J Biochem; 1978 Oct; 84(4):843-53. PubMed ID: 711701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant chymotrypsin inhibitor 2: expression, kinetic analysis of inhibition with alpha-chymotrypsin and wild-type and mutant subtilisin BPN', and protein engineering to investigate inhibitory specificity and mechanism.
    Longstaff C; Campbell AF; Fersht AR
    Biochemistry; 1990 Aug; 29(31):7339-47. PubMed ID: 2207109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.